PCH - Hemophagocytic Lymphohistiocytosis "HLH: 101 to 2025" - Ashish Kumar, MD, PhD (Cincinnati Children's - Cincinnati, OH)

Delayed CME credit is available for up to 4 weeks following the live session
Please note: providers must be affiliated with Phoenix Children's (medical staff and referring) 
 

Watch Eligible Videos

Claim CME credit

About this presenter:

Ashish Kumar, MD, PhD
Professor of Pediatrics
Co-director, Histiocytosis Center
Cincinnati Children's

Dr. Ashish Kumar is a physician-scientist in the division of Bone marrow transplant and Immune Deficiency at the Cancer and Blood Disease Institute at Cincinnati Children's Hospital Medical Center (CCHMC), and Professor of Pediatrics at the University of Cincinnati College of Medicine. At CCHMC, he is the director of the multi-disciplinary Histiocytosis Center. Before joining CCHMC in 2009, Dr. Kumar worked as an Assistant Professor at the University of Minnesota Medical School.

Dr. Kumar’s current focus is on Langerhans cell histiocytosis (LCH) and hemophagocytic lymphohistiocytosis (HLH). Based on research and experience, he has completely changed the approach to treatment for diseases like Langerhans cell histiocytosis (LCH), where he doesn't use chemotherapy at all. Instead, novel oral inhibitors have revolutionized the outcomes for patients with this condition. He also has a different way of diagnosing patients with hemophagocytic lymphohistiocytosis (HLH), which has resulted in improved outcomes.

In his free time, he enjoys traveling, hiking and cooking. He loves music, although the only instrument he can play is the air guitar.

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Arizona College of Medicine - Tucson and Phoenix Children's. The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Arizona College of Medicine - Tucson designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

Relevant Financial Relationships Statement(s):

University of Arizona College of Medicine - Tucson Office of Continuing Medical Education adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). The CME office reviewers have nothing to disclose. All relevant financial relationships have been mitigated prior to the commencement of the activity.